CE Mark for PrisMax system and its TherMax blood warmer. - Baxter International

Baxer International Inc. announced the company received CE mark of both its PrisMax system and its TherMax blood warmer. PrisMax is the company�s next-generation technology for continuous renal replacement and organ support therapies. Designed with input from more than 650 healthcare practitioners around the world, the PrisMax system features innovative technology to make delivering therapy simpler and more efficient while also improving treatment accuracy in the ICU.

Baxter kicked off the launch of the PrisMax system at the 2018 European Society of Intensive Care Medicine (ESICM) congress in Paris.

Building on Baxter�s leading Prismaflex technology currently used by hospitals in more than 90 countries, the PrisMax system, in combination with specialty dialyzers, delivers a complete range of extracorporeal (outside the body) therapies to remove waste products, excess fluids and inflammatory mediators, to help manage patients with acute kidney injury (AKI), and as an aid in sepsis management. AKI is an increasingly common complication of acute illnesses in intensive care units and hospitals.

�Our assessment of the PrisMax system across seven ICUs in six countries concluded that the device features several important enhancements that contribute to safety, efficiency and user friendliness. The launch of PrisMax is a big step forward for clinicians� abilities to treat patients in the ICU more effectively,� said Marcus Broman, M.D., Department of Perioperative and Intensive Care of Sk�ne University Hospital in Lund, Sweden, and lead author of a publication about the results.

The TherMax blood warmer, which is used alongside the PrisMax system, is a critical component for extracorporeal therapies as a patient�s blood is purified outside of the body and must be at a certain temperature prior to returning to the body. TherMax uses a bi-directional connection with the PrisMax system to help meet warming targets by automatically adjusting heating to meet the prescribed return blood temperature. The TherMax blood warmer also includes several advanced patient safety features to help control blood return temperature, detect leaks, and to ensure the correct setup.

Comment: Baxter intends to commercially launch PrisMax and TherMax in more than 19 countries across Europe, with hospitals in Denmark, France, Italy and Sweden to be among the first to receive the new devices.